Bayesian Capital Management’s PetMed Express PETS Stock Holding History

Bayesian Capital Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,120	Closed	-$218K	–	650
2020 Q2	$218K	Sell	6,120 -4,100	-40%	-$142K	0.05%	423
2020 Q1	$294K	Buy	10,220 +691	+7%	+$18.1K	0.06%	459
2019 Q4	$224K	Buy	+9,529	New	+$213K	0.04%	507
2018 Q1	–	Sell	-8,588	Closed	-$391K	–	761
2017 Q4	$391K	Sell	8,588 -5,800	-40%	-$229K	0.08%	366
2017 Q3	$477K	Buy	14,388 +9,400	+188%	+$383K	0.11%	277
2017 Q2	$203K	Buy	+4,988	New	+$155K	0.07%	368
2016 Q3	–	Sell	-10,084	Closed	-$189K	–	463
2016 Q2	$189K	Buy	+10,084	New	+$185K	0.11%	337

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bayesian Capital Management's PETS Position: Q3 2020 in Review

Bayesian Capital Management sold out of PetMed Express (PETS) in Q3 2020, closing a stake of 6,120 shares — an estimated $218K sold.

Bayesian Capital Management first reported a position in PETS in Q2 2016 and held it in 7 quarters. The position peaked at $477K in Q3 2017. 201 funds tracked by Wall St. Rank hold PETS as of Q3 2020.

Bayesian Capital Management reported no remaining PetMed Express position as of Q3 2020 after selling out during the quarter.
Bayesian Capital Management sold 6,120 PetMed Express shares in Q3 2020, an estimated $218K.
Bayesian Capital Management first reported a position in PetMed Express in Q2 2016 and held it in 7 quarters.
Bayesian Capital Management's PetMed Express position peaked at $477K in Q3 2017.
201 funds tracked by Wall St. Rank held PetMed Express as of Q3 2020.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.